These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

768 related items for PubMed ID: 10986126

  • 1. High-resolution solution structure of the catalytic fragment of human collagenase-3 (MMP-13) complexed with a hydroxamic acid inhibitor.
    Moy FJ, Chanda PK, Chen JM, Cosmi S, Edris W, Levin JI, Powers R.
    J Mol Biol; 2000 Sep 22; 302(3):671-89. PubMed ID: 10986126
    [Abstract] [Full Text] [Related]

  • 2. High-resolution solution structure of the inhibitor-free catalytic fragment of human fibroblast collagenase determined by multidimensional NMR.
    Moy FJ, Chanda PK, Cosmi S, Pisano MR, Urbano C, Wilhelm J, Powers R.
    Biochemistry; 1998 Feb 10; 37(6):1495-504. PubMed ID: 9484219
    [Abstract] [Full Text] [Related]

  • 3. NMR solution structure of the catalytic fragment of human fibroblast collagenase complexed with a sulfonamide derivative of a hydroxamic acid compound.
    Moy FJ, Chanda PK, Chen JM, Cosmi S, Edris W, Skotnicki JS, Wilhelm J, Powers R.
    Biochemistry; 1999 Jun 01; 38(22):7085-96. PubMed ID: 10353819
    [Abstract] [Full Text] [Related]

  • 4. Crystal structure of human macrophage elastase (MMP-12) in complex with a hydroxamic acid inhibitor.
    Nar H, Werle K, Bauer MM, Dollinger H, Jung B.
    J Mol Biol; 2001 Sep 28; 312(4):743-51. PubMed ID: 11575929
    [Abstract] [Full Text] [Related]

  • 5. Crystal structure of the stromelysin catalytic domain at 2.0 A resolution: inhibitor-induced conformational changes.
    Chen L, Rydel TJ, Gu F, Dunaway CM, Pikul S, Dunham KM, Barnett BL.
    J Mol Biol; 1999 Oct 29; 293(3):545-57. PubMed ID: 10543949
    [Abstract] [Full Text] [Related]

  • 6. High-resolution solution structure of basic fibroblast growth factor determined by multidimensional heteronuclear magnetic resonance spectroscopy.
    Moy FJ, Seddon AP, Böhlen P, Powers R.
    Biochemistry; 1996 Oct 22; 35(42):13552-61. PubMed ID: 8885834
    [Abstract] [Full Text] [Related]

  • 7. Crystal structures of the catalytic domain of human stromelysin-1 (MMP-3) and collagenase-3 (MMP-13) with a hydroxamic acid inhibitor SM-25453.
    Kohno T, Hochigai H, Yamashita E, Tsukihara T, Kanaoka M.
    Biochem Biophys Res Commun; 2006 May 26; 344(1):315-22. PubMed ID: 16603129
    [Abstract] [Full Text] [Related]

  • 8. Homology modeling of gelatinase catalytic domains and docking simulations of novel sulfonamide inhibitors.
    Kiyama R, Tamura Y, Watanabe F, Tsuzuki H, Ohtani M, Yodo M.
    J Med Chem; 1999 May 20; 42(10):1723-38. PubMed ID: 10346925
    [Abstract] [Full Text] [Related]

  • 9. Structural basis for the highly selective inhibition of MMP-13.
    Engel CK, Pirard B, Schimanski S, Kirsch R, Habermann J, Klingler O, Schlotte V, Weithmann KU, Wendt KU.
    Chem Biol; 2005 Feb 20; 12(2):181-9. PubMed ID: 15734645
    [Abstract] [Full Text] [Related]

  • 10. Structure of recombinant mouse collagenase-3 (MMP-13).
    Botos I, Meyer E, Swanson SM, Lemaître V, Eeckhout Y, Meyer EF.
    J Mol Biol; 1999 Oct 01; 292(4):837-44. PubMed ID: 10525409
    [Abstract] [Full Text] [Related]

  • 11. Solution structure of the catalytic domain of human collagenase-3 (MMP-13) complexed to a potent non-peptidic sulfonamide inhibitor: binding comparison with stromelysin-1 and collagenase-1.
    Zhang X, Gonnella NC, Koehn J, Pathak N, Ganu V, Melton R, Parker D, Hu SI, Nam KY.
    J Mol Biol; 2000 Aug 11; 301(2):513-24. PubMed ID: 10926524
    [Abstract] [Full Text] [Related]

  • 12. Substrate specificity determinants of human macrophage elastase (MMP-12) based on the 1.1 A crystal structure.
    Lang R, Kocourek A, Braun M, Tschesche H, Huber R, Bode W, Maskos K.
    J Mol Biol; 2001 Sep 28; 312(4):731-42. PubMed ID: 11575928
    [Abstract] [Full Text] [Related]

  • 13. Solution structure and backbone dynamics of the catalytic domain of matrix metalloproteinase-2 complexed with a hydroxamic acid inhibitor.
    Feng Y, Likos JJ, Zhu L, Woodward H, Munie G, McDonald JJ, Stevens AM, Howard CP, De Crescenzo GA, Welsch D, Shieh HS, Stallings WC.
    Biochim Biophys Acta; 2002 Jul 29; 1598(1-2):10-23. PubMed ID: 12147339
    [Abstract] [Full Text] [Related]

  • 14. Design and synthesis of phosphinamide-based hydroxamic acids as inhibitors of matrix metalloproteinases.
    Pikul S, McDow Dunham KL, Almstead NG, De B, Natchus MG, Anastasio MV, McPhail SJ, Snider CE, Taiwo YO, Chen L, Dunaway CM, Gu F, Mieling GE.
    J Med Chem; 1999 Jan 14; 42(1):87-94. PubMed ID: 9888835
    [Abstract] [Full Text] [Related]

  • 15. Solution structure of Delta 5-3-ketosteroid isomerase complexed with the steroid 19-nortestosterone hemisuccinate.
    Massiah MA, Abeygunawardana C, Gittis AG, Mildvan AS.
    Biochemistry; 1998 Oct 20; 37(42):14701-12. PubMed ID: 9778345
    [Abstract] [Full Text] [Related]

  • 16. High-resolution solution structure of the EGF-like domain of heregulin-alpha.
    Jacobsen NE, Abadi N, Sliwkowski MX, Reilly D, Skelton NJ, Fairbrother WJ.
    Biochemistry; 1996 Mar 19; 35(11):3402-17. PubMed ID: 8639490
    [Abstract] [Full Text] [Related]

  • 17. Solution structure of a sweet protein single-chain monellin determined by nuclear magnetic resonance and dynamical simulated annealing calculations.
    Lee SY, Lee JH, Chang HJ, Cho JM, Jung JW, Lee W.
    Biochemistry; 1999 Feb 23; 38(8):2340-6. PubMed ID: 10029527
    [Abstract] [Full Text] [Related]

  • 18. The solution structure of bovine ferricytochrome b5 determined using heteronuclear NMR methods.
    Muskett FW, Kelly GP, Whitford D.
    J Mol Biol; 1996 Apr 26; 258(1):172-89. PubMed ID: 8613986
    [Abstract] [Full Text] [Related]

  • 19. Solution structure of the catalytic domain of gammadelta resolvase. Implications for the mechanism of catalysis.
    Pan B, Maciejewski MW, Marintchev A, Mullen GP.
    J Mol Biol; 2001 Jul 27; 310(5):1089-107. PubMed ID: 11501998
    [Abstract] [Full Text] [Related]

  • 20. Solution structure of the catalytic domain of human stromelysin complexed with a hydrophobic inhibitor.
    Van Doren SR, Kurochkin AV, Hu W, Ye QZ, Johnson LL, Hupe DJ, Zuiderweg ER.
    Protein Sci; 1995 Dec 27; 4(12):2487-98. PubMed ID: 8580839
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 39.